Upgrade to SI Premium - Free Trial

ANI Pharma (ANIP)

83.00 +0.71 (0.86%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/12/26)

Latest Headlines

Form 4 ANI PHARMACEUTICALS INC For: Jun 12 Filed by: Cook Meredith June 15, 2026 6:44 PM - SEC Filing Form 4 ANI PHARMACEUTICALS INC For: May 21 Filed by: Thoma Jeanne June 10, 2026 9:10 PM - SEC Filing Form 4 ANI PHARMACEUTICALS INC For: May 21 Filed by: TANNENBAUM RENEE P June 10, 2026 9:09 PM - SEC Filing Form 4 ANI PHARMACEUTICALS INC For: May 21 Filed by: Pera Antonio R June 10, 2026 9:08 PM - SEC Filing Form 4 ANI PHARMACEUTICALS INC For: May 21 Filed by: Leonard Matthew J June 10, 2026 9:08 PM - SEC Filing Form 4 ANI PHARMACEUTICALS INC For: May 21 Filed by: HAUGHEY THOMAS June 10, 2026 9:07 PM - SEC Filing Form 4 ANI PHARMACEUTICALS INC For: Jun 05 Filed by: CAREY STEPHEN P. June 9, 2026 6:34 PM - SEC Filing Form 144 ANI PHARMACEUTICALS INC Filed by: HAUGHEY THOMAS June 8, 2026 4:37 PM - SEC Filing Form 144 ANI PHARMACEUTICALS INC Filed by: CAREY STEPHEN P. June 5, 2026 4:48 PM - SEC Filing ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference May 27, 2026 6:50 AM - StreetInsider Form 8-K ANI PHARMACEUTICALS INC For: May 21 May 21, 2026 4:13 PM - SEC Filing Form 4 ANI PHARMACEUTICALS INC For: May 11 Filed by: Walsh Patrick D May 13, 2026 8:22 PM - SEC Filing Form 4 ANI PHARMACEUTICALS INC For: May 12 Filed by: Rowland Thomas Andrew May 13, 2026 4:17 PM - SEC Filing Form 4 ANI PHARMACEUTICALS INC For: May 11 Filed by: Lalwani Nikhil May 13, 2026 4:17 PM - SEC Filing Form 4 ANI PHARMACEUTICALS INC For: May 12 Filed by: Gutwerg Ori May 13, 2026 4:16 PM - SEC Filing Form 4 ANI PHARMACEUTICALS INC For: May 13 Filed by: Cook Meredith May 13, 2026 4:16 PM - SEC Filing Form 144 ANI PHARMACEUTICALS INC Filed by: Walsh Patrick D May 13, 2026 11:05 AM - SEC Filing Form 8-K ANI PHARMACEUTICALS INC For: May 13 May 13, 2026 8:28 AM - SEC Filing Form 144 ANI PHARMACEUTICALS INC Filed by: Lalwani Nikhil May 11, 2026 6:35 PM - SEC Filing Form 144 ANI PHARMACEUTICALS INC Filed by: Walsh Patrick D May 11, 2026 4:51 PM - SEC Filing Form 10-Q ANI PHARMACEUTICALS INC For: Mar 31 May 8, 2026 6:58 AM - SEC Filing ANI Pharma (ANIP) Tops Q1 EPS by 60c ; Offers Guidance May 8, 2026 6:57 AM - StreetInsider Form 8-K ANI PHARMACEUTICALS INC For: May 08 May 8, 2026 6:56 AM - SEC Filing ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance May 8, 2026 6:50 AM - Globe NewsWire ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET April 24, 2026 6:50 AM - Globe NewsWire ANI Pharmaceuticals launches generic Pimozide tablets with exclusivity April 20, 2026 6:50 AM - StreetInsider ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity April 20, 2026 6:50 AM - Globe NewsWire Form 4 ANI PHARMACEUTICALS INC For: Apr 13 Filed by: Cook Meredith April 13, 2026 4:41 PM - SEC Filing ANI Pharmaceuticals launches generic carbamazepine capsules April 13, 2026 6:53 AM - StreetInsider ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules April 13, 2026 6:50 AM - Globe NewsWire Form ARS ANI PHARMACEUTICALS INC For: Dec 31 April 9, 2026 4:15 PM - SEC Filing Form DEFA14A ANI PHARMACEUTICALS INC April 9, 2026 4:13 PM - SEC Filing Form DEF 14A ANI PHARMACEUTICALS INC For: Dec 31 April 9, 2026 4:12 PM - SEC Filing ANI Pharmaceuticals launches generic isosorbide mononitrate tablets April 8, 2026 6:50 AM - StreetInsider ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet April 8, 2026 6:50 AM - Globe NewsWire Form 8-K ANI PHARMACEUTICALS INC For: Apr 01 April 7, 2026 4:21 PM - SEC Filing ANI Pharmaceuticals announces ILUVIEN trial results published in Ophthalmology April 7, 2026 8:44 AM - StreetInsider ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology April 7, 2026 8:44 AM - Globe NewsWire ANI Pharmaceuticals publishes ILUVIEN trial results in Ophthalmology journal April 7, 2026 6:50 AM - StreetInsider ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology April 7, 2026 6:50 AM - StreetInsider Jefferies Reiterates Buy Rating on ANI Pharmaceuticals (ANIP) following Keenova report March 31, 2026 10:07 AM - StreetInsider Form SCHEDULE 13G/A ANI PHARMACEUTICALS INC Filed by: VANGUARD GROUP INC March 26, 2026 3:50 PM - SEC Filing Barclays Reiterates Overweight Rating on ANI Pharmaceuticals (ANIP): 'expect a strong recovery here' March 18, 2026 12:32 PM - StreetInsider Full Article List